{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:16:16Z","timestamp":1770066976681,"version":"3.49.0"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.3892\/ol.2017.6342","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T06:23:05Z","timestamp":1496902985000},"page":"1691-1696","source":"Crossref","is-referenced-by-count":10,"title":["Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites"],"prefix":"10.3892","volume":"14","author":[{"given":"Xuefeng","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"key20180108115342_b1-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108115342_b2-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180108115342_b3-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10120-011-0085-6","article-title":"Gastric cancer treatment in Japan: 2008 nnual report of the JGCA nationwide registry","volume":"14","author":"Isobe","year":"2011","journal-title":"Gastric Cancer"},{"key":"key20180108115342_b4-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","article-title":"S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial","volume":"9","author":"Koizumi","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180108115342_b5-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0959-8049(98)00211-1","article-title":"Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients","volume":"34","author":"Sakata","year":"1998","journal-title":"Eur J Cancer"},{"key":"key20180108115342_b6-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"key20180108115342_b7-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ejso.2000.1033","article-title":"Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis","volume":"27","author":"McQuellon","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"key20180108115342_b8-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"1100","key":"key20180108115342_b9-ol-0-0-6342","first-page":"1102","article-title":"Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy","volume":"78","author":"Glockzin","year":"2007","journal-title":"Chirurg"},{"key":"key20180108115342_b10-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.2006.08.0135","article-title":"Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: A randomized phase II trial of the Swiss Group for Clinical Cancer Research","volume":"25","author":"Roth","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180108115342_b11-ol-0-0-6342","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"key20180108115342_b12-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","article-title":"Intraperitoneal antineoplastic drug delivery: Rationale and results","volume":"4","author":"Markman","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20180108115342_b13-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00015458.2004.11679577","article-title":"Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis","volume":"104","author":"Detroz","year":"2004","journal-title":"Acta Chir Belg"},{"key":"key20180108115342_b14-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: Rationale and technique","volume":"2","author":"Gonz\u00e1lez-Moreno","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"key20180108115342_b15-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/157016309787581084","article-title":"Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy","volume":"6","author":"Van der Speeten","year":"2009","journal-title":"Curr Drug Discov Technol"},{"key":"key20180108115342_b16-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","article-title":"A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy","volume":"2","author":"Yan","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"key20180108115342_b17-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20180108115342_b18-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2016.08.006","article-title":"Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review","volume":"49","author":"Tozzoli","year":"2016","journal-title":"Clin Biochem"},{"key":"key20180108115342_b19-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejso.2010.09.006","article-title":"Surgical treatment for peritoneal carcinomatosis from gastric cancer","volume":"36","author":"Yonemura","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"key20180108115342_b20-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","article-title":"Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma","volume":"24","author":"Yan","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108115342_b21-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: Systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108115342_b22-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Association Fran\u00e7aise de Chirurgie: Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20180108115342_b23-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s101200100013","article-title":"A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP)","volume":"4","author":"Kim","year":"2001","journal-title":"Gastric Cancer"},{"key":"key20180108115342_b24-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch Surg"},{"key":"key20180108115342_b25-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108115342_b26-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejso.2007.12.003","article-title":"Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience","volume":"34","author":"Scaringi","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"key20180108115342_b27-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jso.21324","article-title":"Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery","volume":"100","author":"Yonemura","year":"2009","journal-title":"J Surg Oncol"},{"key":"key20180108115342_b28-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","article-title":"Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin","volume":"69","author":"Los","year":"1994","journal-title":"Br J Cancer"},{"key":"key20180108115342_b29-ol-0-0-6342","first-page":"237","volume-title":"Peritoneal Dissemination","author":"Yonemura","year":"1998"},{"key":"key20180108115342_b30-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00280-013-2122-0","article-title":"Society for Study of Peritoneal Carcinomatosis in Gastric Cancer: Phase I\/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis","volume":"71","author":"Fushida","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108115342_b31-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1055-3207(03)00050-4","article-title":"Intraperitoneal chemotherapy with mitoxantrone in malignant ascites","volume":"12","author":"Link","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180108115342_b32-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20180108115342_b33-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9610(99)00162-2","article-title":"Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma","volume":"178","author":"Bando","year":"1999","journal-title":"Am J Surg"},{"key":"key20180108115342_b34-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000012086","article-title":"Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure","volume":"58","author":"Sugarbaker","year":"2000","journal-title":"Oncology"},{"key":"key20180108115342_b35-ol-0-0-6342","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","article-title":"Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors","volume":"63","author":"Chu","year":"1989","journal-title":"Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:06:24Z","timestamp":1569438384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,8]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.3892\/ol.2017.6342"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6342","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}